Reza M Mohamadi
Overview
Explore the profile of Reza M Mohamadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muhanna N, Eu D, Chan H, Douglas C, Townson J, Di Grappa M, et al.
BMC Cancer
. 2021 Oct;
21(1):1075.
PMID: 34600526
Background: Monitoring circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs), known as liquid biopsies, continue to be developed as diagnostic and prognostic markers for a wide variety of cancer...
2.
Labib M, Wang Z, Ahmed S, Mohamadi R, Duong B, Green B, et al.
Nat Biomed Eng
. 2020 Jul;
5(1):41-52.
PMID: 32719513
Molecular-level features of tumours can be tracked using single-cell analyses of circulating tumour cells (CTCs). However, single-cell measurements of protein expression for rare CTCs are hampered by the presence of...
3.
Wang Z, Gagliardi M, Mohamadi R, Ahmed S, Labib M, Zhang L, et al.
Sci Adv
. 2020 May;
6(12):eaay7629.
PMID: 32440533
The ability to detect rare human pluripotent stem cells (hPSCs) in differentiated populations is critical for safeguarding the clinical translation of cell therapy, as these undifferentiated cells have the capacity...
4.
Green B, Nguyen V, Atenafu E, Weeber P, Duong B, Thiagalingam P, et al.
Anal Chem
. 2019 Jul;
91(15):9348-9355.
PMID: 31264404
The analysis of circulating tumor cells (CTCs) provides a means to collect information about the evolving properties of a tumor during cancer progression and treatment. For patients with metastatic prostate...
5.
Nemr C, Smith S, Liu W, Mepham A, Mohamadi R, Labib M, et al.
Anal Chem
. 2019 Jan;
91(4):2847-2853.
PMID: 30676721
The spread of antibiotic-resistant bacteria poses a global threat to public health. Conventional bacterial detection and identification methods often require pre-enrichment and/or sample preprocessing and purification steps that can prolong...
6.
Bass R, Roberto D, Wang D, Cantu F, Mohamadi R, Kelley S, et al.
Anticancer Res
. 2018 Dec;
39(1):113-118.
PMID: 30591447
Background/aim: Desmopressin is a synthetic analogue of the antidiuretic hormone vasopressin. It has recently been demonstrated to inhibit tumor progression and metastasis in breast cancer models. Docetaxel is a chemotherapy...
7.
Labib M, Mohamadi R, Poudineh M, Ahmed S, Ivanov I, Huang C, et al.
Nat Chem
. 2018 Apr;
10(5):489-495.
PMID: 29610463
Cell-to-cell variation in gene expression creates a need for techniques that can characterize expression at the level of individual cells. This is particularly true for rare circulating tumour cells, in...
8.
Green B, Kermanshah L, Labib M, Ahmed S, Silva P, Mahmoudian L, et al.
ACS Appl Mater Interfaces
. 2017 May;
9(24):20435-20443.
PMID: 28548481
Isolating subpopulations of heterogeneous cancer cells is an important capability for the meaningful characterization of circulating tumor cells at different stages of tumor progression and during the epithelial-to-mesenchymal transition. Here,...
9.
Mohammadi S, Busa L, Maeki M, Mohamadi R, Ishida A, Tani H, et al.
Anal Sci
. 2016 Dec;
32(12):1359-1362.
PMID: 27941268
We demonstrated a rapid immunoassay for detection of cat cystatin C (cCys-C) which is an important marker for chronic kidney disease in cats, using immuno-pillar chips. The required amount of...
10.
Poudineh M, Labib M, Ahmed S, Nguyen L, Kermanshah L, Mohamadi R, et al.
Angew Chem Int Ed Engl
. 2016 Nov;
56(1):163-168.
PMID: 27897359
During cancer progression, tumors shed circulating tumor cells (CTCs) into the bloodstream. CTCs that originate from the same primary tumor can have heterogeneous phenotypes and, while some CTCs possess benign...